Drug-eluting Microspheres Compared to Conventional Transarterial Chemoembolization as First Line Treatment for Unresectable Hepatocellular Carcinoma: A Single-center Retrospective Cost-utility Analysis.
G AndreozziValentina LorenzoniI BargelliniR CioniG TurchettiPublished in: Cardiovascular and interventional radiology (2023)
The higher prices of DEMs are counterbalanced by the positive impact on QALY.